PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Jan-2020 CollPlant Partners in the Advanced Regenerative Manufacturing Institute CollPlant
06-Jan-2020 Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe Allergan plc
06-Jan-2020 BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma EMD Serono
06-Jan-2020 Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference Anixa Biosciences, Inc.
06-Jan-2020 Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer Antengene Corporation
03-Jan-2020 AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference AbbVie
03-Jan-2020 Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK Conference  SMi Group
02-Jan-2020 Avantor® to Participate in the J.P. Morgan Healthcare Conference Avantor and Financial News
02-Jan-2020 EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES Evotec SE
02-Jan-2020 GSK completes divestment of rabies and tick-borne encephalitis vaccines to Bavarian Nordic GSK
02-Jan-2020 Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features) Expedeon AG
02-Jan-2020 CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs CF PharmTech, Inc.
31-Dec-2019 111 Named "National High-tech Enterprise" by the Government 111, Inc.
31-Dec-2019 MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc. MagForce AG
31-Dec-2019 MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc. MagForce AG
30-Dec-2019 MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA (news with additional features) MorphoSys AG
30-Dec-2019 PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE HANA PHARM IN SOUTH KOREA PAION AG
30-Dec-2019 PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE HANA PHARM IN SOUTH KOREA PAION AG
27-Dec-2019 First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL (news with additional features) MorphoSys AG
27-Dec-2019 Pivotal Phase 3 Study of DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia Disorder Published in JAMA Network Open Eisai Inc.